Cite
Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro
MLA
Carson W. Reed, et al. “Development and Profiling of MGlu7 NAMs with a Range of Saturable Inhibition of Agonist Responses in Vitro.” Bioorganic & Medicinal Chemistry Letters, vol. 74, Oct. 2022, p. 128923. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e65e5c3f23be6d3ebd95797ab4cb3865&authtype=sso&custid=ns315887.
APA
Carson W. Reed, Alice L. Rodriguez, Jacob J. Kalbfleisch, Mabel Seto, Matthew T. Jenkins, Anna L. Blobaum, Sichen Chang, Craig W. Lindsley, & Colleen M. Niswender. (2022). Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro. Bioorganic & Medicinal Chemistry Letters, 74, 128923.
Chicago
Carson W. Reed, Alice L. Rodriguez, Jacob J. Kalbfleisch, Mabel Seto, Matthew T. Jenkins, Anna L. Blobaum, Sichen Chang, Craig W. Lindsley, and Colleen M. Niswender. 2022. “Development and Profiling of MGlu7 NAMs with a Range of Saturable Inhibition of Agonist Responses in Vitro.” Bioorganic & Medicinal Chemistry Letters 74 (October): 128923. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e65e5c3f23be6d3ebd95797ab4cb3865&authtype=sso&custid=ns315887.